Summary
Updated Aug 30, 2026
Jeffrey Scott Riley is Director of Gain Therapeutics, Inc. (GANX). 1 SEC Form 4 filing on record, dated 17 July 2026.
Trading Pattern
InsiderAlpha's records for Jeffrey Scott Riley go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Jeffrey Scott Riley's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $38.76M of MLYS open-market activity in the last 12 months
- Dirk Kersten - $38.57M of DYN open-market activity in the last 12 months
- Ari Bousbib - $38.55M of IQV open-market activity in the last 12 months
- Mark J. Tarr - $38.47M of EHC open-market activity in the last 12 months
- Helen Torley - $37.86M of HALO open-market activity in the last 12 months
- Kevin Charles Gorman - $37.82M of NBIX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jeffrey Scott Riley?
Jeffrey Scott Riley is a corporate insider, tracked as Director of Gain Therapeutics, Inc. (GANX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey Scott Riley submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Jeffrey Scott Riley's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jeffrey Scott Riley and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial